ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

4,42
-0,06
(-1,34%)
Fermé 21 Novembre 10:00PM
4,42
0,00
( 0,00% )
Avant marché: 10:19AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
4,42
Prix Achat
4,42
Prix Vente
5,36
Volume échangé
-
0,00 Fourchette du Jour 0,00
2,28 Plage de 52 semaines 6,70
Cap du marché
Clôture Veille
4,42
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 054 815
Actions en circulation
147 579 486
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,90
Bénéfice par action (BPA)
-1,53
Chiffre d'affairess
170,28M
Bénéfice net
-225,25M

À propos de Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Olympia, Washington, USA
Fondé
-
Adaptive Biotechnologies Corporation est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ADPT. Le dernier cours de clôture d'Adaptive Biotechnologies était de US$4,42. Au cours de la dernière année, les actions de Adaptive Biotechnologies ont été négociées dans une fourchette de prix de US$ 2,28 à US$ 6,70.

Adaptive Biotechnologies compte actuellement 147 579 486 actions en circulation. La capitalisation boursière d'Adaptive Biotechnologies est de US$652,30 million. Adaptive Biotechnologies a un ratio cours/bénéfice (ratio PE) de -2.90.

ADPT Dernières nouvelles

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate...

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.41-24.18524871365.835.834.3314179294.75816664CS
4-0.36-7.531380753144.786.74.3311730785.2453349CS
12-0.13-2.857142857144.556.73.98110548154.94756581CS
260.8824.85875706213.546.72.9912448754.33485748CS
520.020.4545454545454.46.72.2813978783.99212558CS
156-22.96-83.856829802827.3830.512.2812829737.47089103CS
260-24.06-84.480337078728.4871.252.28113111617.84640225CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
WORXSCWorx Corporation
US$ 2,03
(107,14%)
13,22M
AKTSAkoustis Technologies Inc
US$ 0,1358
(55,91%)
29,39M
PETWag Group Company
US$ 0,315
(49,93%)
14,22M
CCECCapital Clean Energy Carriers Corporation
US$ 24,99
(34,72%)
9
VEEAVeea Inc
US$ 3,74
(32,62%)
3,08M
WSBFWaterstone Financial Inc
US$ 9,00
(-40,98%)
4
TRSTriMas Corporation
US$ 15,62
(-40,79%)
1
BCAXBicara Therapeutics Inc
US$ 11,00
(-40,15%)
104
PYXSPyxis Oncology Inc
US$ 2,33
(-39,01%)
164,45k
XNCRXencor Inc
US$ 15,11
(-36,30%)
2
AKTSAkoustis Technologies Inc
US$ 0,1358
(55,91%)
29,39M
PETWag Group Company
US$ 0,315
(49,93%)
14,22M
WORXSCWorx Corporation
US$ 2,03
(107,14%)
13,22M
XTKGX3 Holdings Company Ltd
US$ 0,0776
(-13,78%)
10,42M
ELABElevai Labs Inc
US$ 0,0201
(-6,07%)
3,56M
Aucune Discussion Trouvée
Ajouter une Discussion